CYCLERION THERAPEUTICS, INC. (KRSA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading KRSA…

CYCLERION THERAPEUTICS, INC. (KRSA) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

CYCLERION THERAPEUTICS, INC.

KRSA · CIK 1755237

4 · Sep 10, 2026 · Director Shah Nimish P was granted 48.45K Stock Option (Right to Buy)

4

Director Shah Nimish P was granted 48.45K Stock Option (Right to Buy)

Filed: Sep 10, 2026
Period: Sep 9, 2026
Accession: 0001193125-26-388144
Filer: Korsana Biosciences, Inc.

View on SEC.gov All SEC filings

Filing document

xslF345X06/ownership.xml

xslF345X06/ownership.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4ownership.xml
Open SEC.gov